ArticleAmerican journal of cancer research2022

Risk stratification of hepatocellular carcinoma incidence using a fibrosis-4-based prediction model in patients with chronic hepatitis C receiving antiviral therapy: a nationwide real-world Taiwanese cohort study.

Hung-Wei Wang et al.PubMed ↗Full text ↗

No numbers read from the abstract.